Literature DB >> 29395052

Japan Strengthens Regenerative Medicine Oversight.

Douglas Sipp1, Hideyuki Okano2.   

Abstract

The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy.
Copyright © 2018 Elsevier Inc. All rights reserved.

Mesh：

Year:  2018        PMID： 29395052     DOI： 10.1016/j.stem.2018.01.001

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  6 in total

Review 1.  The Role of Mesenchymal Stem Cells in Radiation-Induced Lung Fibrosis.

Authors:  Michele Zanoni; Michela Cortesi; Alice Zamagni; Anna Tesei
Journal:  Int J Mol Sci       Date:  2019-08-08       Impact factor: 5.923

Review 2.  Adoption of Regulations for Cell Therapy Development: Linkage Between Taiwan and Japan.

Authors:  Teng-Huang Tsai; Thai-Yen Ling; Chung-Hsi Lee
Journal:  Clin Transl Sci       Date:  2020-06-07       Impact factor: 4.689

Review 3.  Reflection on the enactment and impact of safety laws for regenerative medicine in Japan.

Authors:  Kayo Takashima; Michael Morrison; Jusaku Minari
Journal:  Stem Cell Reports       Date:  2021-05-20       Impact factor: 7.765

Review 4.  Development and regulation of stem cell-based therapies in China.

Authors:  Jianchao Gao; Chenyan Gao
Journal:  Cell Prolif       Date:  2022-04-13       Impact factor: 8.755

Review 5.  Concise Review: Laying the Groundwork for a First-In-Human Study of an Induced Pluripotent Stem Cell-Based Intervention for Spinal Cord Injury.

Authors:  Osahiko Tsuji; Keiko Sugai; Ryo Yamaguchi; Syoichi Tashiro; Narihito Nagoshi; Jun Kohyama; Tsuyoshi Iida; Toshiki Ohkubo; Go Itakura; Miho Isoda; Munehisa Shinozaki; Kanehiro Fujiyoshi; Yonehiro Kanemura; Shinya Yamanaka; Masaya Nakamura; Hideyuki Okano
Journal:  Stem Cells       Date:  2018-11-12       Impact factor: 6.277

6.  Regulated, reliable, and reputable: Protect patients with uniform standards for stem cell treatments.

Authors:  Geoffrey P Lomax; Art Torres; Maria T Millan
Journal:  Stem Cells Transl Med       Date:  2020-02-10       Impact factor: 6.940
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.